GlaxoSmithKline resumed operations at the main building on its Zebulon campus Monday, six days after the discovery of Legionella bacteria forced the pharmaceutical company to shut down the facility.
GlaxoSmithKline resumed operations at the main building on its Zebulon campus Monday, six days after the discovery of Legionella bacteria forced the pharmaceutical company to shut down the facility. AARON MOODY amoody@newsobserver.com
GlaxoSmithKline resumed operations at the main building on its Zebulon campus Monday, six days after the discovery of Legionella bacteria forced the pharmaceutical company to shut down the facility. AARON MOODY amoody@newsobserver.com

GSK reopens Zebulon plant

August 17, 2015 02:19 PM